HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor
- PMID: 2565808
- PMCID: PMC400786
- DOI: 10.1002/j.1460-2075.1989.tb03361.x
HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor
Abstract
We have investigated the biological function of an unidentified human growth factor, the ligand of the putative HER2 receptor, by characterizing the signalling properties of its receptor. HER2 (or c-erbB-2), the human homolog of the rat neu proto-oncogene, encodes a transmembrane glycoprotein of the tyrosine kinase family that appears to play an important role in human breast carcinoma. Since a potential ligand for HER2 has not yet been identified, it has been difficult to analyze the biochemical properties and biological function of this cell surface protein. For this reason, we replaced the HER2 extracellular domain with the closely related ligand binding domain sequences of the epidermal growth factor (EGF) receptor, and examined the ligand-induced biological signalling potential of this chimeric HER1-2 protein. This HER1-2 receptor is targetted to the cell surface of transfected NIH 3T3 cells, forms high and low affinity binding sites, and generates normal mitogenic and cell transforming signals upon interaction with EGF or TGF alpha. The constitutive activation of wild-type HER2 in transfected NIH 3T3 cells suggests the possibility that these cells synthesize the as yet unidentified HER2 ligand and activate HER2 by an autocrine mechanism.
Similar articles
-
A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.EMBO J. 1989 Jan;8(1):159-66. doi: 10.1002/j.1460-2075.1989.tb03360.x. EMBO J. 1989. PMID: 2565807 Free PMC article.
-
A chimeric EGFR/neu receptor in studies of neu function.Cancer Treat Res. 1992;61:213-28. doi: 10.1007/978-1-4615-3500-3_11. Cancer Treat Res. 1992. PMID: 1360234 Review. No abstract available.
-
The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.New Biol. 1990 Nov;2(11):992-1003. New Biol. 1990. PMID: 1983208
-
Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins.J Biol Chem. 1993 May 25;268(15):11134-42. J Biol Chem. 1993. PMID: 8098709
-
Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.Cancer Treat Res. 1992;61:139-60. doi: 10.1007/978-1-4615-3500-3_7. Cancer Treat Res. 1992. PMID: 1360229 Review. No abstract available.
Cited by
-
Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.Oncotarget. 2017 Jan 3;8(1):1884-1912. doi: 10.18632/oncotarget.12242. Oncotarget. 2017. PMID: 27683128 Free PMC article. Review.
-
Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor.Mol Cell Biol. 1990 May;10(5):2407-12. doi: 10.1128/mcb.10.5.2407-2412.1990. Mol Cell Biol. 1990. PMID: 1691441 Free PMC article.
-
The EGF receptor family--multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4.Trans Am Clin Climatol Assoc. 2003;114:315-33; discussion 333-4. Trans Am Clin Climatol Assoc. 2003. PMID: 12813928 Free PMC article. Review.
-
Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.Mol Cell Biol. 1995 Dec;15(12):6582-92. doi: 10.1128/MCB.15.12.6582. Mol Cell Biol. 1995. PMID: 8524223 Free PMC article.
-
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.EMBO J. 1993 Mar;12(3):961-71. doi: 10.1002/j.1460-2075.1993.tb05737.x. EMBO J. 1993. PMID: 8096177 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous